ReviewSchwann cell transplantation and descending propriospinal regeneration after spinal cord injury

- Schwann cell (SC) is a promising treatment for spinal cord injury (SCI).
- Propriospinal (PS) axons have powerful intrinsic capacity to regenerate.
- SCs promote extensive propriospinal regeneration.
- This review focuses on optimizing SCs transplantation strategy for PS regeneration.
- This discussion will benefit the clinical trial of SCs transplantation for SCI.

After spinal cord injury (SCI), poor ability of damaged axons of the central nervous system (CNS) to regenerate causes very limited functional recovery. Schwann cells (SCs) have been widely explored as promising donors for transplantation to promote axonal regeneration in the CNS including the spinal cord. Compared with other CNS axonal pathways, injured propriospinal tracts display the strongest regenerative response to SC transplantation. Even without providing additional neurotrophic factors, propriospinal axons can grow into the SC environment which is rarely seen in supraspinal tracts. Propriospinal tract has been found to respond to several important neurotrophic factors secreted by SCs. Therefore, the SC is considered to be one of the most promising candidates for cell-based therapies for SCI. Since many reviews have already appeared on topics of SC transplantation in SCI repair, this review will focus particularly on the rationale of SC transplantation in mediating descending propriospinal axonal regeneration as well as optimizing such regeneration by using different combinatorial strategies.This article is part of a Special Issue entitled SI: Spinal cord injury.